Rising Prevalence of Cardiac Conditions Drives the Heart Failure POC & LOC Devices Market
The rising global burden of cardiovascular diseases is driving the demand for advanced diagnostic technologies. Heart failure, one of the leading causes of hospitalization worldwide, requires timely diagnosis and management. The Heart Failure POC & LOC Devices Market is gaining momentum as healthcare providers seek rapid, accurate, and cost-effective solutions.
According to industry analysis, the global market was valued at USD 110.5 million in 2021 and is projected to reach USD 225.1 million by 2030, growing at a CAGR of 8.2% during the forecast period. This growth reflects the increasing adoption of point-of-care (POC) and lab-on-chip (LOC) devices that enable early detection of heart failure biomarkers.
Rising cases of hypertension, obesity, and diabetes are further accelerating demand for portable diagnostic devices. Hospitals, clinics, and home care providers are increasingly integrating these technologies to enhance patient monitoring. Moreover, growing awareness about the importance of early cardiac screening has made POC and LOC devices an integral part of preventive cardiology.
With continuous advancements in biosensor technology and the integration of AI-driven analytics, the Heart Failure POC & LOC Devices Market is positioned for robust expansion. The focus on reducing hospital readmissions, improving survival rates, and lowering healthcare costs will remain central to its growth trajectory.